This investment will allow IMIDomics to accelerate the identification of new therapeutic targets and the development of new drugs for immune-mediated inflammatory diseases (IMID), like rheumatoid arth...
Read moreEsta estrategia ha proporcionado facilidades de derivación desde atención primaria y ha localizado pacientes aún sin diagnosticar
Read moreConjugated dienes can be found in a wide range of biologically active natural products and functional materials. However, these compounds are also of particular interest given their application in syn...
Read moreA study carried out by Hospital Clínic-IDIBAPS has determined that complement factor H (CFH), a protein of the complement system, plays a role in AMD through its regulation of both inflammation and o...
Read moreEl proyecto Hipernav ha empleado el casco Hololens de Microsoft en el campo clínico para afinar la precisión durante la extirpación de tumores
Read moreInvestigadores de la Universidad Politécnica de Madrid y la Universidad de Manchester analizan el impacto que tienen las nuevas tecnologías que se conectan a la red de distribución en la calidad de...
Read moreThe Biomedical Genomics laboratory at IRB Barcelona has developed a computational tool that identifies cancer driver mutations for each tumour type. This and other developments produced by the same l...
Read moreInvestigadores del Instituto Picower del Instituto de Tecnología de Massachusetts revelan que las neuronas y las células gliales rompen su ADN en posiciones concretas durante la formación de memori...
Read moreEl trabajo analiza la microbiota de dos géneros de estos parásitos que afectan a la salud humana y señala que existen 1.800 especies de bacterias en su tracto digestivo
Read moreIt is the first time it has been possible to see how neurotransmitters and proteins interact at the atomic level to trigger neuronal responses.
Read moreUn estudio del Hospital de Bellvitge, el IDIBELL y la Icahn School of Medicine de Mount Sinai, en Nueva York publicado en la revista Nature Communications, ha demostrado por primera vez que el fenóme...
Read moreOryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, today reported ...
Read more